908 Devices Inc (MASS)
5.76
-0.01
(-0.17%)
USD |
NASDAQ |
May 10, 12:01
908 Devices Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0787 |
| September 30, 2022 | 0.0763 |
| June 30, 2022 | 0.0746 |
| March 31, 2022 | 0.0725 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0699 |
| September 30, 2021 | 0.1222 |
| June 30, 2021 | 0.1184 |
| March 31, 2021 | 0.1125 |
| December 31, 2020 | 0.1067 |
| September 30, 2020 | 2.376 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.2338 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.2338
Minimum
Dec 2019
2.376
Maximum
Sep 2020
0.1859
Average
0.0736
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.0229 |
| Retractable Technologies Inc | 0.0155 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
| Catheter Precision Inc | 0.0087 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 189.79M |
| Total Liabilities (Quarterly) | 32.90M |
| Shareholders Equity (Quarterly) | 156.89M |
| Current Ratio | 8.374 |
| Net Debt Paydown Yield | 1.21% |